Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Abroad (travel likely)RecruitingPHASE1

Conditions

GEP-NET · Gastroenteropancreatic Neuroendocrine Tumor · Gastroenteropancreatic Neuroendocrine Tumor Disease · Neuroendocrine Tumors · Carcinoid · Carcinoid Tumor · Pancreatic NET · Solid Tumor · Somatostatin Receptor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Research Facility, Iowa City, Iowa, United States

  • Research Facility, Lexington, Kentucky, United States

  • Research Facility, St Louis, Missouri, United States

  • Research Facility, St Louis, Missouri, United States

  • Research Facility, Columbus, Ohio, United States

  • Research Facility, Nashville, Tennessee, United States

  • Research Facility, Salt Lake City, Utah, United States

  • Research Facility, Toronto, Ontario, Canada

  • Research Facility, Montreal, Quebec, Canada

Study leads
  • Ye Yuan, MD

    Study Director

    RayzeBio, Inc.